Connect Biopharma Holdings Ltd is trading at $2.18 (5.6% up) in pre-market, extending a strong after-hours move from June 15 amid broader risk-on sentiment.
- The stock is building on momentum from the previous session, where it rose from $2.06 to $2.20 during after-hours trading.
- There are no fresh company-specific filings, clinical updates, or deal announcements to serve as a new identifiable catalyst.
- The current strength appears to be driven by recent positive price action and a generally optimistic market tone.